Chantal J. Boisvert

Chantal J. Boisvert

Auto-generated profile, based on publicly available information

Chantal J. Boisvert

Ophthalmology (C.J.B.), Duke University School of Medicine, Durham, NC

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2005 in Nature Medicine
Verified
Journal Article
Open access
PDF file
EKElsa Kermorvant-Duchemin
Elsa Kermorvant-Duchemin
FSFlorian Sennlaub
Florian Sennlaub
MSMirna Sirinyan
Mirna Sirinyan
SBSonia Brault
Sonia Brault
GAGregor Andelfinger
Gregor Andelfinger
SCSylvain Chemtob
Sylvain Chemtob
Nitrative stress has an important role in microvascular degeneration leading to ischemia in conditions such as diabetic retinopathy and retinopathy of prematurity. Thus far, mediators of nitrative stress have been poorly characterized. We recently described that trans-arachidonic acids are major products of NO2•-mediated isomerization of arachidonic acid within the cell membrane, but their biological relevance is unknown. Here we show that trans-arachidonic acids are generated in a model of retinal microangiopathy in vivo in a NO•-dependent manner. They induce a selective time- and concentration-dependent apoptosis of microvascular endothelial cells in vitro, and result in retinal microvascular degeneration ex vivo and in vivo. These effects are mediated by an upregulation of the antiangiogenic factor thrombospondin-1, independently of classical arachidonic acid metabolism. Our findings provide new insight into the molecular mechanisms of nitrative stress in microvascular injury and suggest new therapeutic avenues in the management of disorders involving nitrative stress, such as ischemic retinopathies and encephalopathies.

1 November 2016 in Ophthalmology
Verified
Journal Article
Closed access
CSClaire A. Sheldon
Claire A. Sheldon
GPGrace L. Paley
Grace L. Paley
RXRui Xiao
Rui Xiao
AKAnat Kesler
Anat Kesler
OEOri Eyal
Ori Eyal
GLGrant T. Liu
Grant T. Liu

1 September 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
BGBrian Mac Grory
Brian Mac Grory
SLSean R. Landman
Sean R. Landman
PZPaul D. Ziegler
Paul D. Ziegler
CBChantal J. Boisvert
Chantal J. Boisvert
SFShane P. Flood
Shane P. Flood
SYShadi Yaghi
Shadi Yaghi
Background: Central retinal artery occlusion (CRAO) causes sudden, irreversible blindness and is a form of acute ischemic stroke. In this study, we sought to determine the proportion of patients in whom atrial fibrillation (AF) is detected by extended cardiac monitoring after CRAO. Methods: We performed a retrospective, observational cohort study using data from the Optum deidentified electronic health record of 30.8 million people cross-referenced with the Medtronic CareLink database of 2.7 million people with cardiac monitoring devices in situ. We enrolled patients in 3 groups: (1) CRAO, (2) cerebral ischemic stroke, and (3) age-, sex-, and comorbidity-matched controls. The primary end point was the detection of new AF (defined as ≥2 minutes of AF detected on a cardiac monitoring device). Results: We reviewed 884 431 patient records in common between the two databases to identify 100 patients with CRAO, 6559 with ischemic stroke, and 1000 matched controls. After CRAO, the cumulative incidence of new AF at 2 years was 49.6% (95% CI, 37.4%–61.7%). Patients with CRAO had a higher rate of AF than controls (hazard ratio, 1.64 [95% CI, 1.17–2.31]) and a comparable rate to patients with stroke (hazard ratio, 1.01 [95% CI, 0.75–1.36]). CRAO was associated with a higher incidence of new stroke compared with matched controls (hazard ratio, 2.85 [95% CI, 1.29–6.29]). Conclusions: The rate of AF detection after CRAO is higher than that seen in age-, sex-, and comorbidity-matched controls and comparable to that seen after ischemic cerebral stroke. Paroxysmal AF should be considered as part of the differential etiology of CRAO, and those patients may benefit from long-term cardiac monitoring.

20 February 2017 in Developmental Neurobiology
Verified
Journal Article
Closed access
PDF file
SNSamuel U. Nummela
Samuel U. Nummela
SCShanna H. Coop
Shanna H. Coop
SCShaun L. Cloherty
Shaun L. Cloherty
CBChantal J. Boisvert
Chantal J. Boisvert
MLMathias Leblanc
Mathias Leblanc
JMJude F. Mitchell
Jude F. Mitchell

1 July 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
BGBrian Mac Grory
Brian Mac Grory
MSMatthew Schrag
Matthew Schrag
SPSven Poli
Sven Poli
CBChantal J. Boisvert
Chantal J. Boisvert
Martin SpitzerMartin Spitzer
Martin Spitzer
WFWuwei Feng
Wuwei Feng

7 August 2018 in Current Eye Research
Verified
Journal Article
Closed access
JYJeffrey J. Yu
Jeffrey J. Yu
DLDaniel H. Lee
Daniel H. Lee
SGShea P. Gallagher
Shea P. Gallagher
Maria Cristina KenneyMaria Cristina Kenney
Maria Cristina Kenney
CBChantal J. Boisvert
Chantal J. Boisvert
There is growing evidence for the role of mitochondrial dysfunction in the toxic optic neuropathies. Due to the structural similarities between antibiotic targets and mitochondrial machinery, several antibiotics known to cause optic neuropathy have deleterious effects on mitochondrial function. We review the literature on the prevalence, clinical manifestations, and management of antibiotic induced toxic optic neuropathies. The effect of these antibiotics on mitochondrial function in regard to the optic nerve is discussed.